QuesGen Systems, Inc. Announces Traumatic Brain Injury (TBI) Focused Partnership with Moberg Research

    SAN FRANCISCO, CA, August 12, 2016 /24-7PressRelease/ -- QuesGen Systems, Inc., a provider of research services to organizations and investigators developing treatments for brain health and Traumatic Brain Injury (TBI), is pleased to announce the formation of a business relationship with Moberg Research, Inc.. Moberg has developed a revolutionary platform for data integration called the Component Neuromonitoring System (CNS). Moberg is working to build the first "smart" Neuro Intensive Care Unit (ICU) as part of a global effort to improve treatment and outcomes for patients with brain injury.

QuesGen System's comprehensive TBI data management platform and Moberg's CNS are both being used within leading TBI studies such as UCSF-based TRACK-TBI and European-based CENTER-TBI. QuesGen will be able to collect key summary variables that are generated from the large volumes of data from the Moberg CNS Monitor. Prominent TBI Studies like CENTER-TBI and TRACK-TBI are using the Moberg CNS Monitor for tracking data for severe TBI patients.

About Moberg Research: Moberg Research, Inc. is a privately owned medical device manufacturing company specializing in neurological patient monitoring solutions for acute care. Moberg research was founded in 1998 and is located in Ambler, PA in the greater Philadelphia area. For more information about Moberg Research, visit www.moberg.com

About QuesGen: QuesGen Systems, Inc. (www.quesgen.com) provides data management and study resources to organizations, with the primary focus on TBI and brain health. QuesGen is working with TRACK-TBI (11 medical centers across the US), CENTER-TBI (72 centers across Europe), CENTER-TBI/China (40 centers in China), CARE (Prospective TBI study in 30,000 college athletes) and many others.

For more information about QuesGen Systems, please contact Barbara Maley, 650-727-0611; email: [email protected]

For more information about Moberg Research, Inc., please contact Cheryl McDonald, 215-283-0860 x210; email: [email protected]

# # #